Investing.com - Privia Health Group (NASDAQ: PRVA) reported first quarter EPS of $0.18, $0.13 better than the analyst estimate of $0.05. Revenue for the quarter came in at $415.2M versus the consensus estimate of $393.05M.
Guidance
Privia Health Group sees FY 2024 revenue of $1.60B-$1.68B versus the analyst consensus of $1.64B.
Privia Health Group's stock price closed at $18.86. It is down -9.72% in the last 3 months and down -32.04% in the last 12 months.
Privia Health Group saw 1 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Privia Health Group's stock price’s past reactions to earnings here.
According to InvestingPro, Privia Health Group's Financial Health score is "great performance".
Check out Privia Health Group's recent earnings performance, and Privia Health Group's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar